Stock listing

Dusseldorf:SH0 Shionogi & Co., Ltd. Aktie

German listing (Dusseldorf) of Shionogi & Co., Ltd. · home listing Tokyo:4507

Follow Shionogi & Co., Ltd. into a list and get an email when it puts out news.

Share price · DUS:SH0

€16.59 EUR +0.09 (+0.5%)

Close on Oct 20, 2026

Day range
€16.45 – €16.59 EUROct 20, 2026
Market cap
€18.47B EURAt the close on Oct 20, 2026 · price × 1.11B shares outstanding
Shionogi & Co., Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
OTC:SGIOY$9.27 USD+0.09 (+1.0%)400$9.27$9.27$9.27$9.18Close on Oct 19, 2026
OTC:SGIOF$18.00 USD0.00 (0.0%)—$18.00$18.00$18.00$18.00Close on Oct 19, 2026
Frankfurt:SH0€15.93 EUR-0.005 (0.0%)—€15.93€15.93€15.93€15.94Close on Oct 20, 2026
Munich:SH0€16.73 EUR+0.265 (+1.6%)—€16.69€16.73€16.69€16.47Close on Oct 20, 2026
Dusseldorf:SH0€16.59 EUR+0.085 (+0.5%)—€16.45€16.59€16.45€16.51Close on Oct 20, 2026
Ticker
Dusseldorf:SH0
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Dusseldorf
Currency
EUR

What changed lately

Calls

Replays

  • Shionogi & (Tokyo:4507) Q3 2024 Earnings Call

    Fri, Jan 31, 2025 · 3:30 AM ET

    Watch Transcript

  • Shionogi & (Tokyo:4507) Q2 2024 Earnings Call

    Tue, Oct 29, 2024 · 2:00 AM ET

    Watch Transcript

  • Shionogi & (Tokyo:4507) Q1 2024 Earnings Call

    Mon, Jul 29, 2024 · 4:00 AM ET

    Watch Transcript

Latest news

Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.

Oct 5, 2026

COVGOZE for Intramuscular Injection (JN.1-adapted), Recombinant Protein COVID-19 Vaccine, Receives Partial Change Approval in Japan

Sep 16, 2026

Shionogi Announces U.S. Government Procurement of Fetroja through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats

Aug 31, 2026

Consolidated Financial Results for the First Quarter of Fiscal Year 2026 (IFRS)

Aug 3, 2026

Shionogi Recognizes the Four-Year Anniversary of RADICAVA ORS® (edaravone) for Treatment of ALS

Jul 30, 2026

Shionogi Announces U.S. Availability of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure*

Jul 28, 2026

Notice of Completion of Disposal of Treasury Shares as Restricted Stock Compensation Plan

Jul 23, 2026

Kirin Group and Blackmores to Launch New Cognizin® Cognitive Support Supplements in Australia and New Zealand

Jul 22, 2026

FDA Accepts Shionogi’s sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria

Jul 16, 2026

Notice of Disposal of Treasury Shares as Restricted Stock Compensation Plan

Jun 24, 2026

All Shionogi & Co., Ltd. news

Decks

Shionogi & Co., Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
31 in the last 12 months · 50 in all · newest Oct 5, 2026 · oldest 2025
Calls
7 calls with a replay · 7 with a transcript · latest Jan 31, 2025
Decks
34 decks · latest Aug 3, 2026

Where Shionogi & Co., Ltd. is listed

ListingExchangeCountryCurrency
Tokyo:4507 塩野義製薬 · Home listingTokyoJapanJPY
gettex:SH0gettexGermanyEUR
OTC:SGIOYOTCUnited StatesUSD
OTC:SGIOFOTCUnited StatesUSD
LS Exchange:855648LS ExchangeGermanyEUR
Lang & Schwarz:855648Lang & SchwarzGermanyEUR
gettex:SH00gettexGermanyEUR
Frankfurt:SH0FrankfurtGermanyEUR
Munich:SH0MunichGermanyEUR
Tradegate:SH0TradegateGermanyEUR
BMV:4507NBMVMexicoMXN
Dusseldorf:SH0 · This pageDusseldorfGermanyEUR
Stuttgart:SH0StuttgartGermanyEUR
BIVA:4507NBIVAMexicoMXN
Munich:SH00MunichGermanyEUR
Hamburg:SH0HamburgGermanyEUR
Hanover:SH0HanoverGermanyEUR

Log in to ask 6ix AI your own questions about Shionogi & Co., Ltd.